While MPNST remains a challenging malignancy, several promising advances are underway: MEK Inhibitors in NF1-Associated MPNST Given the dysregulation of the RAS/RAF/MEK pathway in NF1-related tumors, MEK inhibitors like selumetinib have shown efficacy in benign plexiform neurofibromas
Kawai, J
Obesity can impact your quality of life and raise your risk of heart disease, high blood pressure, unhealthy cholesterol levels, type 2 diabetes, fatty liver disease, sleep apnea, osteoarthritis, depression and cancer
Partial response suggests your GLP-1 pathway is active but insufficient on its own
This product is provided solely for laboratory research use and is not a drug product
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study